Consumer Reports recently corrected a story to run in its May issue, titled “Vitamin D: How 32 supplements really measure up," that erroneously identified nine vitamin D/calcium supplement products that the publication claimed exceeded the California Proposition 65 Lead Limit for Reproductive Risk.
The National Advertising Division last week recommended that Interhealth Nutraceuticals discontinue certain claims for the company’s Zychrome dietary supplements, products that are promoted for the management of insulin levels.
Generic drug maker Actavis is settling a patent-infringement suit with Purdue Pharma concerning the opioid painkiller OxyContin, Actavis said, saying it expected to make more than $100 million in the deal between 2014 and 2015.
More than 1.3 million emergency room visits in 2010 were related to abuse of prescription drugs, and the problem has become widespread enough that the Centers for Disease Control and Prevention classifies it as an epidemic. In response, curbing abuse of prescription drugs has become a cornerstone of the Obama administration's drug policy.
The Marketplace Fairness Act is one step closer to passing. The Senate voted 63-30 to end debate on the bill, which would compel online retailers to collect state taxes, and will make a final decision on the bill on May 6.
The House Committee on Energy and Commerce Subcommittee on Health heard testimony on Thursday morning from representatives of the Food and Drug Administration and several industry trade groups following the introduction of draft legislation that sponsors said would strengthen the country's pharmaceutical supply chain.
Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.
A dramatic jump in the rates of misuse of prescription stimulants over the past four years is linked to lax attitudes on the part of parents, according to a new study, though misuse and abuse of prescription opioids has remained flat.
As the retail pharmacy industry continues to explore outcome-based solutions to help drive down the cost of overall health care, incoming National Association of Chain Drug Stores chairman Robert Narveson pointed to the oath a pharmacist takes for inspiration during his inaugural address here before attendees of the 2013 NACDS Annual Meeting.
During the National Association of Chain Drug Stores Annual Meeting today, the association elected the new officers, two new executive committee members and four new board of directors members for the coming year.